Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -52.44% is 40% above its 5-year average of -86.82%, near the high end of its 5-year range (-146.20%–-33.18%).
As of the fiscal period ended Tuesday, June 30, 2026. 41.27% above its 12-month average of -89.30%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -52.44%.
RETURN ON INVESTED CAPITAL (ROIC)
-52.44%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-89.30%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-104.28%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-86.82%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+41.27%
CURRENT VS 3Y AVG
+49.71%
CURRENT VS 5Y AVG
+39.59%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-31.40%
median of 552 covered companies
CURRENT VS SECTOR MEDIAN
-67.05%
vs the sector median at left
Damora Therapeutics, Inc.
Market Cap
$1.16B
Return on Invested Capital (ROIC)
-52.44%
TTM Avg
-89.30%
3Y Avg
-104.28%
5Y Avg
-86.82%
Market Cap
$1.16B
Return on Invested Capital (ROIC)
3.72%
TTM Avg
3.50%
3Y Avg
1.32%
5Y Avg
-2.22%
Market Cap
$1.17B
Return on Invested Capital (ROIC)
-67.73%
TTM Avg
-67.73%
3Y Avg
-67.73%
5Y Avg
-67.73%
Market Cap
$1.13B
Return on Invested Capital (ROIC)
1.81%
TTM Avg
7.83%
3Y Avg
4.30%
5Y Avg
3.30%
Market Cap
$1.21B
Return on Invested Capital (ROIC)
1.32%
TTM Avg
13.41%
3Y Avg
0.51%
5Y Avg
-22.96%
Market Cap
$1.22B
Return on Invested Capital (ROIC)
9.48%
TTM Avg
1.29%
3Y Avg
-3.62%
5Y Avg
0.10%
Market Cap
$1.11B
Return on Invested Capital (ROIC)
5.93%
TTM Avg
9.95%
3Y Avg
11.37%
5Y Avg
9.31%
Market Cap
$1.22B
Return on Invested Capital (ROIC)
1.12%
TTM Avg
-4.20%
3Y Avg
-6.46%
5Y Avg
-10.06%
Market Cap
$1.22B
Return on Invested Capital (ROIC)
-57.11%
TTM Avg
-57.11%
3Y Avg
-57.11%
5Y Avg
-57.11%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Damora Therapeutics, Inc. (DMRA) | $1.16B | -52.44% | -89.30% | -104.28% | -86.82% |
| GoodRx Holdings, Inc. (GDRX)vs › | $1.16B | 3.72% | 3.50% | 1.32% | -2.22% |
| Avalyn Pharma Inc. Common Stock (AVLN)vs › | $1.17B | -67.73% | -67.73% | -67.73% | -67.73% |
| Harrow Health, Inc. (HROW)vs › | $1.13B | 1.81% | 7.83% | 4.30% | 3.30% |
| MannKind Corporation (MNKD)vs › | $1.21B | 1.32% | 13.41% | 0.51% | -22.96% |
| Innovage Holding Corp. (INNV)vs › | $1.22B | 9.48% | 1.29% | -3.62% | 0.10% |
| Amphastar Pharmaceuticals, Inc. (AMPH)vs › | $1.11B | 5.93% | 9.95% | 11.37% | 9.31% |
| Cronos Group Inc. (CRON)vs › | $1.22B | 1.12% | -4.20% | -6.46% | -10.06% |
| Kardigan, Inc. (KARD)vs › | $1.22B | -57.11% | -57.11% | -57.11% | -57.11% |
| Bicara Therapeutics Inc. Common Stock (BCAX)vs › | $1.10B | -42.98% | -26.82% | -23.95% | -23.95% |
ROIC
-52.4%
ROE
-50.9%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -52.44% |
| 2026-03-31 | -46.73% |
| 2025-12-31 | -87.69% |
| 2025-09-30 | -146.20% |
| 2025-06-30 | -113.45% |
| 2025-03-31 | -99.48% |
| 2024-12-31 | -105.96% |
| 2024-09-30 | -96.06% |
| 2024-06-30 | -93.62% |
| 2024-03-31 | -101.38% |
| 2023-12-31 | -111.90% |
| 2023-09-30 | -116.34% |
| 2023-06-30 | -116.86% |
| 2023-03-31 | -113.21% |
| 2022-12-31 | -97.84% |
| 2022-09-30 | -83.10% |
| 2022-06-30 | -70.61% |
| 2022-03-31 | -54.50% |
| 2021-12-31 | -44.23% |
| 2021-09-30 | -38.34% |
| 2021-06-30 | -33.18% |
